Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb (Q68133857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

S Bertolini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

N Elicio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M L Degl'Innocenti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

R Balestreri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M G Fusi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A M Cotta Ramusino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A Carozzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

25-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01061412

22 September 2019

exact match

0 references

cites work

Cholesterol lowering and the reduction of coronary heart disease risk

1 reference

12 December 2020

Cholesterol and coronary heart disease. A new era.

1 reference

12 December 2020

Fenofibrate treatment inhibits HMG-CoA reductase activity in mononuclear cells from hyperlipoproteinemic patients

1 reference

12 December 2020

Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure

1 reference

12 December 2020

Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels

1 reference

12 December 2020

Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man

1 reference

12 December 2020

Inhibition of membrane-bound hepatic 3 hydroxy-3 methyl glutaryl CoA reductase as the consequence of altered membrane fluidity

1 reference

12 December 2020

Consensus conference. Lowering blood cholesterol to prevent heart disease

1 reference

12 December 2020

Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia

1 reference

12 December 2020

[Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)]

1 reference

12 December 2020

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

1 reference

12 December 2020

[Pharmacology of fenofibrate (author's transl)]

1 reference

12 December 2020

Fenofibrate therapy of hyperlipoproteinaemia a dose—response study and a comparison with clofibrate

1 reference

12 December 2020

Simple and rapid method for determining procetofenic acid, an active metabolite of procetofen, in biological fluids by solid-phase extraction and high-performance liquid chromatography

1 reference

12 December 2020

Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects

1 reference

12 December 2020

Fenofibrate therapy of hypertriglyceridaemia. Differential effects on LDL cholesterol level in type IV and in type IIb primary hyperlipoproteinaemia

1 reference

12 December 2020

Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias

1 reference

12 December 2020

Clinical pharmacokinetic study of procetofene, a new hypolipidemic drug, in volunteers

1 reference

12 December 2020

Estimation of VLDL cholesterol in hyperlipidemia.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01061412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3282894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference